Delivery Order SPE2D021D0005-SPE2D326F4685
Award Date 1/27/26
Potential Completion Date 1/28/26
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Department's Medical Supply Chain has awarded a delivery order to Genentech USA, Inc. for TNKase 50 mg kits, valued at $16,109.55. The contract, issued on July 30, 2025, with an ultimate completion date of August 4, 2025, represents a firm fixed-price procurement with no set-aside designation. Performance will take place at Genentech's headquarters in South San Francisco, California. TNKase (tenecteplase) is a thrombolytic medication used in acute myocardial infarction...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to Genentech USA, Inc. for TNKase 50 mg kits with a ceiling value of $16,109.55. This firm fixed-price delivery order, executed on August 15, 2025, is scheduled for completion by August 20, 2025, and will be performed at Genentech's facility in South San Francisco, California. TNKase (tenecteplase) is a thrombolytic agent used in acute myocardial infarction treatment, representing a critical pharmaceutical product within...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order to Genentech USA, Inc. on September 26, 2025, for TNKase (tenecteplase) 50 mg kits with a ceiling value of $21,479.40. This firm fixed-price delivery order, due for completion by October 1, 2025, represents a short-timeline procurement of this critical stroke treatment medication. The contract was awarded without a set-aside designation, indicating open competition. Genentech, a foreign-owned biotechnology...
- This contract award to Genentech USA, Inc., a foreign-owned, for-profit biotechnology and pharmaceutical manufacturer, is a delivery order valued at $5,369.85 for the supply of TNKASE 50 MG KITS. The award was made by the Defense Logistics Agency (DLA), a defense agency, under a contract with a period of performance ending on April 4, 2025. The contract is a firm fixed-price type without any set-aside designation, indicating open competition. Genentech is a significant supplier of critical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of TNKase 50 mg kits. The contract has a total ceiling value of $15,627.27 and is a firm fixed price delivery order with an ultimate completion date of August 20, 2024. Genentech is a major supplier of pharmaceuticals and biologics to federal agencies, holding several key contract vehicles including a $4.9 billion...
- Genentech USA, Inc. was awarded a $10,055.44 firm fixed price delivery order against an unidentified government-wide acquisition contract by the Defense Logistics Agency Troop Support Medical to provide 4559632188 units of TNKASE 50 MG KITS. The prime contractor will deliver the pharmaceutical products from its facility in South San Francisco, California to the agency by January 18, 2023, fulfilling requirements originally solicited under an unspecified vehicle. No set aside designation or...
- Genentech USA, Inc. was awarded a $4,753.65 firm fixed price delivery order against an unidentified government-wide acquisition contract by the Defense Logistics Agency Troop Support Medical to provide 4558709591 TNKASE 50 MG KITS. Performance will take place in South San Francisco, California over a period of five days from October 6 through October 11, 2022. The Defense Logistics Agency Troop Support Medical supports the Department of Defense by procuring pharmaceuticals, medical supplies, and...
- The Defense Logistics Agency Troop Support Medical awarded a $10,055.44 firm fixed price delivery order to Genentech USA, Inc. of South San Francisco, California. Under the contract, Genentech will provide 4560517576 TNKASE 50 MG KITS to the agency. The place of performance is Genentech's facility in South San Francisco. The period of performance is from April 6, 2023 through April 11, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency Troop Support...
- Genentech USA, Inc. was awarded a $3,260.76 delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide 455,688,378 ACTIVASE 50 MG vials with diluent for injection to the Defense Logistics Agency Troop Support. The place of performance will be Genentech's facility located in South San Francisco, California. The delivery order has a period of performance from April 13, 2022 through April 18, 2022 and utilizes firm fixed...
- Genentech USA, Inc. was awarded a $16,303.80 delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide 50 milligram vials of Activase with diluent for injection. The place of performance will be Genentech's facility located in South San Francisco, California. The delivery order has a period of performance from May 10, 2022 through May 13, 2022 and utilizes firm fixed pricing. No set-aside designation or subcontractors...